Expertise in
5
conditions

Munci A. Yagcı

Gazi, TR 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
5
conditions
Gazi, TR 

Overview

Munci Yagcı practices in Gazi, Turkey. Yagcı is highly rated in 5 conditions, according to our data. Their top areas of expertise are Multiple Myeloma, Chronic B-Cell Leukemia (CBCL), Chronic Lymphocytic Leukemia (CLL), Bone Marrow Transplant, and Tissue Biopsy.

Their clinical research consists of co-authoring 64 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.

Locations

Gazi, Turkey
Other Locations
Besevler, 06500, Turkey
Gazi, Turkey
Besevler, Turkey
Malatya, Turkey

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase 3 Multinational, Multi-center, Single-arm, Open-label Study for the Efficacy and Safety of Radotinib in Ph+ Chronic Phase Chronic Myeloid Leukemia Patients With Failure or Intolerance to Previous TKIs Therapy Including Imatinib
A Phase 3 Multinational, Multi-center, Single-arm, Open-label Study for the Efficacy and Safety of Radotinib in Ph+ Chronic Phase Chronic Myeloid Leukemia Patients With Failure or Intolerance to Previous TKIs Therapy Including Imatinib
Enrollment Status: Recruiting
Publish Date: October 28, 2024
Intervention Type: Drug
Study Drug: Radotinib HCl
Study Phase: Phase 3

64 Total Publications

Clinical Manifestations, Treatment Characteristics, and Clinical Outcomes in Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP) in a Real-World Setting: An Interim Analysis of the Turkish iTTP Registry
Clinical Manifestations, Treatment Characteristics, and Clinical Outcomes in Patients with Immune Thrombotic Thrombocytopenic Purpura (iTTP) in a Real-World Setting: An Interim Analysis of the Turkish iTTP Registry
Journal: Turkish journal of haematology : official journal of Turkish Society of Haematology
Published: July 23, 2025

Frequently Asked Questions about Munci A. Yagcı

Is Munci A. Yagcı a top-rated expert for Multiple Myeloma?

MediFind is an objective health platform that identifies experts based on real-world data. Munci A. Yagcı is classified as an Advanced expert for Multiple Myeloma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Munci A. Yagcı participate in research or clinical trials?

Yes. Munci A. Yagcı has published 64 articles and abstracts on conditions like Multiple Myeloma. You can view a list of Munci A. Yagcı's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yagcı's expertise for a condition
ConditionClose
      View All 16 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile